SNYNF:OTCMKTS
Sanofi SA
USD 78,17
arrow_upward
+1,84%(+1,41) 1D
14 Okt., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SNYNF...
Open
USD 81,34
High
USD 81,34
Low
USD 78,17
Mkt. cap
96,87 mjd
Avg. vol.
5,47 k
Volume
778,00
52-wk high
USD 106,34
52-wk low
USD 76,76
Beta
0,32
Shares outstanding
1,21 mjd
No. of employees
75 k
Open
USD 81,34
High
USD 81,34
Low
USD 78,17
Mkt. cap
96,87 mjd
Avg. vol.
5,47 k
Volume
778,00
52-wk high
USD 106,34
52-wk low
USD 76,76
Beta
0,32
Shares outstanding
1,21 mjd
No. of employees
75 k
News stories
From web sources and news partners
TipRanks
·
12 uur gelede
Sanofi’s RSV Study in Queensland Offers Fresh Clues on Nirsevimab Uptake
Yahoo Finance
·
14 uur gelede
Which Pharma Stock Looks More Attractive: Sanofi or AbbVie?
Euronext Markets: Real-time Stock Market Data | live
·
15 uur gelede
Sanofi avoids fine as EU accepts offer to stop disparaging rival vaccine
ad-hoc-news.de
·
17 uur gelede
Sanofi set October 30 results date as Sanofi stock trades at EUR 70.80
Profile
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOBelén Garijo | Paul Hudson
Employees74,8 k
Founded1973
HeadquartersParys, Île-de-France, Frankryk
SectorPharmaceutical industry
Websitesanofi.com